{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:09:07Z","timestamp":1791223747885,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.coph.2018.01.006","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T16:23:20Z","timestamp":1519143800000},"page":"39-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD"],"prefix":"10.1016","volume":"40","author":[{"given":"Janis K","family":"Shute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermanno","family":"Puxeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2018.01.006_bib0280","series-title":"From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2017"},{"key":"10.1016\/j.coph.2018.01.006_bib0285","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.trsl.2016.01.005","article-title":"Mast cells and their activation in lung disease","volume":"174","author":"Virk","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.coph.2018.01.006_sbref0290","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2147\/COPD.S134161","article-title":"Genetic polymorphism and chronic obstructive pulmonary disease","volume":"12","author":"Yuan","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.coph.2018.01.006_sbref0295","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaci.2017.05.011","article-title":"The environment, epigenome, and asthma","volume":"140","author":"Yang","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2018.01.006_bib0300","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.12688\/f1000research.11978.1","article-title":"Novel therapeutic approaches to simultaneously target rhinovirus infection and asthma\/COPD pathogenesis","volume":"6","author":"Mirabelli","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.coph.2018.01.006_sbref0305","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.it.2017.07.003","article-title":"Neutrophilic inflammation in asthma and association with disease severity","volume":"38","author":"Ray","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coph.2018.01.006_bib0310","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00281-016-0561-5","article-title":"COPD immunopathology","volume":"38","author":"Caramori","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.coph.2018.01.006_bib0315","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.biopha.2017.07.066","article-title":"The participation of oxidative stress in the pathogenesis of bronchial asthma","volume":"94","author":"Kleniewska","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.coph.2018.01.006_bib0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2018.01.006_sbref0325","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jaci.2017.04.005","article-title":"Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients","volume":"139","author":"Loxham","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2018.01.006_bib0330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","article-title":"Role of CFTR in epithelial physiology","volume":"74","author":"Saint-Criq","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.coph.2018.01.006_bib0335","doi-asserted-by":"crossref","first-page":"17406","DOI":"10.1074\/jbc.R113.546218","article-title":"Eosinophil granule proteins: form and function","volume":"289","author":"Acharya","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2018.01.006_bib0340","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.freeradbiomed.2012.09.015","article-title":"Oxidative stress and nitrosative stress are involved at different stages of proteolytic pulmonary emphysema","volume":"53","author":"Lanzetti","year":"2012","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.coph.2018.01.006_bib0345","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6020021","article-title":"Oxidative stress in COPD: sources, markers, and potential mechanisms","volume":"6","author":"McGuinness","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.coph.2018.01.006_bib0350","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1183\/09059180.00004410","article-title":"Mucus hypersecretion in COPD: should we only rely on symptoms?","volume":"19","author":"Burgel","year":"2010","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.coph.2018.01.006_bib0355","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000442794","article-title":"Novel therapies to inhibit mucus synthesis and secretion in airway hypersecretory diseases","volume":"97","author":"Ha","year":"2016","journal-title":"Pharmacology"},{"key":"10.1016\/j.coph.2018.01.006_bib0360","doi-asserted-by":"crossref","first-page":"293053","DOI":"10.1155\/2015\/293053","article-title":"The role of serine proteases and antiproteases in the cystic fibrosis lung","volume":"2015","author":"Twigg","year":"2015","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.coph.2018.01.006_sbref0365","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fimmu.2016.00311","article-title":"Neutrophil extracellular traps in pulmonary diseases: too much of a good thing?","volume":"7","author":"Porto","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2018.01.006_sbref0370","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2147\/COPD.S115969","article-title":"Evidence of eosinophil extracellular trap cell death in COPD: does it represent the trigger that switches on the disease?","volume":"12","author":"Uribe Echevarr\u00eda","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.coph.2018.01.006_sbref0375","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/pr.115.011247","article-title":"Pharmacology of heparin and related drugs","volume":"68","author":"Mulloy","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.coph.2018.01.006_bib0380","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10719-016-9749-0","article-title":"Mast cell glycosaminoglycans","volume":"34","author":"Mulloy","year":"2017","journal-title":"Glycoconj J"},{"key":"10.1016\/j.coph.2018.01.006_bib0385","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1160\/TH08-01-0032","article-title":"Heparin and low-molecular-weight heparin","volume":"99","author":"Gray","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.coph.2018.01.006_bib0390","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1165\/rcmb.2015-0172OC","article-title":"A non-anticoagulant fraction of heparin inhibits leukocyte diapedesis into the lung by an effect on platelets","volume":"55","author":"Riffo-Vasquez","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.coph.2018.01.006_bib0395","first-page":"307","article-title":"Glycosaminoglycan and chemokine\/growth factor interaction","volume":"vol. 207","author":"Shute","year":"2012"},{"key":"10.1016\/j.coph.2018.01.006_bib0400","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.bjp.0707298","article-title":"Size-fractionated heparins have differential effects on human neutrophil function in vitro","volume":"151","author":"Lever","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2018.01.006_bib0405","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2009.12.015","article-title":"Locally available heparin modulates inflammatory cell recruitment in a manner independent of anticoagulant activity","volume":"630","author":"Lever","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2018.01.006_bib0410","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1021\/bi060338r","article-title":"New insights into the inhibition of human neutrophil elastase by heparin","volume":"45","author":"Spencer","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.coph.2018.01.006_bib0415","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2047-783X-15-S2-27","article-title":"Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatment","volume":"15","author":"Demkow","year":"2010","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.coph.2018.01.006_bib0420","doi-asserted-by":"crossref","first-page":"194S","DOI":"10.1042\/bst024194s","article-title":"The antioxidant activity of heparins","volume":"24","author":"Grant","year":"1996","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.coph.2018.01.006_bib0425","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jaci.2012.12.1564","article-title":"Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease","volume":"131","author":"Barnes","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2018.01.006_bib0430","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.thromres.2011.10.003","article-title":"Heparin attenuates lipopolysaccharide induced acute lung injury by inhibiting nitric oxide synthase and TGF\u03b2\/Smad signalling pathway","volume":"129","author":"Mu","year":"2012","journal-title":"Thrombosis Res"},{"key":"10.1016\/j.coph.2018.01.006_bib0435","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1164\/ajrccm\/150.5_Pt_2.S63","article-title":"Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation","volume":"150","author":"Coyle","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coph.2018.01.006_bib0440","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1183\/09031936.00120609","article-title":"Therapeutic implications of the pathophysiology of COPD","volume":"35","author":"Macklem","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coph.2018.01.006_bib0445","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1094-5539(02)00174-8","article-title":"Mechanisms of bronchopulmonary C-fiber hypersensitivity induced by cationic proteins","volume":"16","author":"Lee","year":"2003","journal-title":"Pulmon Pharmacol Therap"},{"key":"10.1016\/j.coph.2018.01.006_sbref0450","doi-asserted-by":"crossref","first-page":"L1240","DOI":"10.1152\/ajplung.00206.2007","article-title":"Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis","volume":"293","author":"Broughton-Head","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.coph.2018.01.006_bib0455","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1164\/ajrccm.162.5.9908107","article-title":"DNA and actin bind and inhibit interleukin-8 function in cystic fibrosis sputa:in vitro effects of mucolytics","volume":"162","author":"Perks","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coph.2018.01.006_bib0460","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI83922","article-title":"Acidic pH increases airway surface liquid viscosity in cystic fibrosis","volume":"126","author":"Tang","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2018.01.006_bib0465","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010525","article-title":"Oxidation increases mucin polymer cross-links to stiffen airway mucus gels","volume":"7","author":"Yuan","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2018.01.006_sbref0470","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/jcm6120112","article-title":"Airway mucus and asthma: the role of MUC5AC and MUC5B","volume":"6","author":"Bonser","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.coph.2018.01.006_bib0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2017.11.013","article-title":"Targeting oxidant-dependent mechanisms for the treatment of respiratory diseases and their comorbidities","volume":"40","author":"Thomson","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.coph.2018.01.006_sbref0480","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/15412555.2017.1347918","article-title":"Impact of mucolytic agents on COPD exacerbations: a pair-wise and network meta-analysis","volume":"14","author":"Cazzola","year":"2017","journal-title":"COPD"},{"key":"10.1016\/j.coph.2018.01.006_bib0485","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1586\/17476348.2016.1121105","article-title":"Oxidation pathway and exacerbations in COPD: the role of NAC","volume":"10","author":"Matera","year":"2016","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.coph.2018.01.006_bib0490","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1183\/16000617.00002215","article-title":"Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis","volume":"24","author":"Cazzola","year":"2015","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.coph.2018.01.006_bib0495","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2500\/ajra.2011.25.3562","article-title":"Heparin inhibits mucus hypersecretion in airway epithelial cells","volume":"25","author":"Ogawa","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.coph.2018.01.006_bib0500","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2332\/allergolint.12-OA-0438","article-title":"The effect of heparin on antigen-induced mucus hypersecretion in the nasal epithelium of sensitized rats","volume":"62","author":"Ogawa","year":"2013","journal-title":"Allergol Int"},{"key":"10.1016\/j.coph.2018.01.006_bib0505","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/thx.2009.114439","article-title":"Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids","volume":"64","author":"Brims","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.coph.2018.01.006_bib0510","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2011-11-391532","article-title":"Asthma and coagulation","volume":"119","author":"de Boer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.coph.2018.01.006_sbref0515","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.thromres.2015.10.011","article-title":"Inhalational use of antithrombotics in humans: review of the literature","volume":"136","author":"Monagle","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.coph.2018.01.006_sbref0520","first-page":"507151","article-title":"Anti-inflammatory effects of heparin and its derivatives: a systematic review","volume":"2015","author":"Mousavi","year":"2015","journal-title":"Adv Pharmacol Sci"},{"key":"10.1016\/j.coph.2018.01.006_sbref0525","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pupt.2017.10.001","article-title":"Inhaled nebulised unfractionated heparin improves lung function in moderate to very severe COPD: a pilot study","volume":"48","author":"Shute","year":"2018","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.coph.2018.01.006_bib0530","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(76)91679-2","article-title":"Intrapulmonary heparin. A new procedure for anticoagulant therapy","volume":"2","author":"Jaques","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2018.01.006_bib0535","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1183\/09031936.02.00105202","article-title":"Effect of inhaled heparin on lung function and coagulation in healthy volunteers","volume":"19","author":"Bendstrup","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coph.2018.01.006_bib0540","doi-asserted-by":"crossref","first-page":"9867","DOI":"10.1073\/pnas.0402891101","article-title":"Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route","volume":"101","author":"Qi","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2018.01.006_bib0545","doi-asserted-by":"crossref","first-page":"e109996","DOI":"10.1371\/journal.pone.0109996","article-title":"Low-molecular-weight heparin and unfractionated heparin decrease Th-1, 2, and 17 expressions","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coph.2018.01.006_sbref0550","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1002\/term.2204","article-title":"Heparin cross-linked collagen sponge scaffolds improve functional regeneration of rat tracheal epithelium","volume":"11","author":"Nakamura","year":"2017","journal-title":"J Tissue Eng Regen Med"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148921730228X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148921730228X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T09:49:09Z","timestamp":1603878549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147148921730228X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":55,"alternative-id":["S147148921730228X"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2018.01.006","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2018.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}